Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Earlier Diagnosis of Pancreatic Cancer: Is It Possible? | Cancers (Basel) | 2023 | 37760400 | PubTator, text mining | PubMed |
| The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation. | Cells | 2023 | 37759430 | PubTator, text mining | PubMed |
| Unravelling the Mystery inside Cells by Using Single-Molecule Fluorescence Imaging. | J Imaging | 2023 | 37754956 | PubTator, text mining | PubMed |
| Endocrine Mucin-Producing Sweat Gland Carcinoma: Case Presentation with a Comprehensive Review of the Literature. | Dermatopathology (Basel) | 2023 | 37754277 | PubTator, text mining | PubMed |
| Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer. | Cancer Rep (Hoboken) | 2023 | 37750497 | PubTator, text mining | PubMed |
| [Role and clinical significance of MUC4 gene mutations in thrombotic events in patients with classic paroxysmal nocturnal hemoglobinuria]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37749036 | PubTator, text mining | PubMed |
| Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. | World J Gastrointest Oncol | 2023 | 37746645 | PubTator, text mining | PubMed |
| Single-cell and genetic multi-omics analysis combined with experiments confirmed the signature and potential targets of cuproptosis in hepatocellular carcinoma. | Front Cell Dev Biol | 2023 | 37745297 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma. | Aging (Albany NY) | 2023 | 37728407 | PubTator, text mining | PubMed |
| mRNA vaccines in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37726283 | PubTator, text mining | PubMed |
| The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer. | Cancer Med | 2023 | 37712717 | PubTator, text mining | PubMed |
| Chromosome-level Dinobdella ferox genome provided a molecular model for its specific parasitism. | Parasit Vectors | 2023 | 37697397 | PubTator, text mining | PubMed |
| Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer. | J Transl Med | 2023 | 37697300 | PubTator, text mining | PubMed |
| Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness. | Front Pharmacol | 2023 | 37693891 | PubTator, text mining | PubMed |
| Expression profiling identifies key genes and biological functions associated with eosinophilic esophagitis in human patients. | Front Allergy | 2023 | 37692891 | PubTator, text mining | PubMed |
| Poorly cohesive duodenal carcinoma mixed with signet ring cell carcinoma with systemic metastasis: a case report and literature review. | Front Oncol | 2023 | 37692856 | PubTator, text mining | PubMed |
| Mucins 3A and 3B Are Expressed in the Epithelium of Human Large Airway. | Int J Mol Sci | 2023 | 37686350 | PubTator, text mining | PubMed |
| Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer. | Int J Mol Sci | 2023 | 37686343 | PubTator, text mining | PubMed |
| CRISPR/Cas-Based Techniques for Live-Cell Imaging and Bioanalysis. | Int J Mol Sci | 2023 | 37686249 | PubTator, text mining | PubMed |
| Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway. | Int J Mol Sci | 2023 | 37685961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=20